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Abstract 
Exercise and physical activity remain the gold standard methods of enhancing and 
maintaining health and wellbeing. However, in populations that benefit most from 
exercise, adherence is often poor and alternatives to exercise are important to bring 
about health improvements. Recent work suggests a role for passive heating (PH) and 
heat shock proteins (HSP) in improving cardio-metabolic health. The aim of this 
study was to investigate the expression of HSP70 and IL-6 in response to either 
exercise (EX) or PH and the subsequent effect on glucose control.  Fourteen males 
volunteered and were categorized lean (BMI 23.5 ± 2.2 Kg.m-2) or overweight (29.2 ± 
2.7 Kg.m-2) and completed 60 minutes of either moderate cycling at a fixed rate of 
metabolic heat production (EX) or warm water immersion in 40˚C water (PH). 
Extracellular HSP70 increased from baseline in both conditions with no differences 
between PH (0.98 ± 1.1 ng.mL-1) or EX (0.84 ± 1.0 ng.mL-1, P=0.814). IL-6 increased 
following both conditions with a 2 fold increase after PH and 4 fold after EX. Energy 
expenditure increased by 61.0 ± 14.4 kcal (79%) after PH. Peak glucose concentration 
after a meal immediately following PH was reduced when compared with EX (6.3 ± 
1.4 mmol.L-1 vs. 6.8 ± 1.2 mmol.L-1; P<0.05). There was no difference in 24-hour 
glucose area under the curve between conditions. These data indicate the potential for 
thermal therapy as a novel treatment and management strategy for type 2 diabetes 
where adherence, or ability to exercise may be compromised. 
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Abbreviations 
AUC – Area under the curve 
BMI – Body mass index 
BP – blood pressure 
BSA – body surface area 
CGM – Continuous glucose monitor 
CI – confidence interval 
CV – coefficient of variation 
eHSP – extracellular heat shock protein 
ELISA - sandwich enzyme-linked immunosorbent assays  
ES – effect size 
EX – Exercise 
HDL-C - High density lipoprotein 
ܪሶ௣௥௢ௗ - Metabolic heat production 
HSP – Heat shock protein 
iHSP – Intracellular heat shock protein 
IL-1ra – Interleukin 1 receptor antagonist 
IL-6 – Interleukin 6 
IL-10 – Interleukin 10 
kDa – kilo Dalton 
LDL-C – Low density lipoprotein 
LEAN – Lean participant group 
OW – Overweight participant group 
PH – Passive heating 
SD – Standard deviation 
SEM – Standard error of mean 
T2DM – Type 2 diabetes mellitus 
Tb  - body temperature 
Tc – core temperature 
Tm – muscle temperature 
Tsk – skin temperature 
TG – Triglyceride 
Vሶ CO2 –carbon dioxide production 
Vሶ O2 – oxygen uptake 
Vሶ O2max – Maximum volume of oxygen uptake 
∆T – change in temperature 
 
 
 
  
Introduction 
 Overweight, obesity and type 2 diabetes mellitus (T2DM) are characterised by 
chronic inflammation and impairments to insulin sensitivity and glucose control. 
Exercise and physical activity remain the gold standard methods of enhancing and 
maintaining health and wellbeing. However, in populations that benefit most from 
exercise, adherence is often poor, most likely due to medical conditions and 
disability,1 poor motivation and a lack of convenience.2,3 There are many factors 
involved in the development and treatment of insulin resistance, with the roles played 
by both thermal therapy 4 and heat shock proteins (HSPs) receiving increased 
attention.5-8 Furthermore, it has been suggested that HSPs may provide an early 
indicator or the onset of metabolic diseases, such as T2DM, before elevations in 
plasma glucose become evident.9,10 
 HSPs are synthesised in response to a number of physiological stressors, such 
as exercise in the heat,11-13 and are individually characterised by their molecular 
weight. The most widely studied HSP in humans is the 70 kDa family of HSPs which 
includes both the constitutive HSP73 and inducible HSP72 forms. HSPs have wide-
ranging functions including their roles as thermo-protectants and involvement in 
protein synthesis.14 The resting level of extracellular HSP70 (eHSP70) appears to be 
related to adiposity and inflammation with elevations reported in obesity and T2DM, 
whereas resting intracellular HSP70 (iHSP70) is decreased in T2DM.10  A reduction 
in iHSP70 is an important component in the vicious cycle of chronic inflammation 
and reduced insulin signalling15,16 and the development of insulin resistance.17,18 
Indeed, a reduction in iHSP70 has been reported in T2DM and correlates to insulin 
resistance and glucose disposal rates.19,20 
 eHSP70 is increased following exercise13 with the magnitude of change 
dependent on both the duration and intensity.21,22 A core temperature (Tc) threshold 
for elevations in eHSP70 has been suggested, with a 0.8-1.5˚C increase in Tc being 
required in order to elevate eHSP7023,24 Recently, thermal therapy has been 
demonstrated to stimulate HSP70 production, although to a lesser extent than 
following exercise,5,24 and may offer an alternative way by which the positive effects 
of HSP may be induced.  
 The influence of thermal therapy on glycemic regulation and metabolic 
disease has primarily been investigated using rodent models.17,18,25-27 Chung et al.,18 
were the first to demonstrate that passive heating of mice resulted in an elevation in 
HSP70 which was protective against the deleterious effects of consuming a high fat 
diet.  Therefore, there is a need to investigate these rodent models and how well they 
translate into human participants. 
There is emerging evidence to suggest that thermal therapy may have long-
term benefits to metabolic and cardiovascular health in humans.4,28 However, the 
mechanisms by which such an effect may occur remain to be elucidated. 
Notwithstanding, there is evidence to support the view that benefits of thermal 
therapy are likely to involve heat shock proteins.10 
Whilst exercise has significant benefits to improving health, individuals with 
many types of chronic disease often experience low exercise tolerance.29 Based on the 
above animal literature, there is evidence to suggest that thermal therapy may 
replicate some of the health benefits of exercise and alleviate some of the 
comorbidities often associated with chronic diseases such as T2DM.30 If successful, 
the implementation of thermal therapy may help to lessen some of the financial 
burden of treating chronic by potentially reducing the dependence on pharmacological 
interventions. Thermal therapy could offer a simple home-based intervention that may 
appeal to individuals unable or unwilling to participate in regular exercise. 
The primary aim of this study was to investigate the expression of eHSP70 in 
response to either exercise (EX) or thermal therapy in the form of passive heating 
(PH) via warm water immersion. A secondary aim was to investigate the effect of 
body composition on the eHSP70 response. Finally, we wished to investigate the 
potential effect of passive heating on glycemic control in response to replicated 
dietary intake. It was hypothesised that both EX and PH would elevate eHSP70, with 
a larger magnitude of change following EX. It was further hypothesised that there 
would be a differential response in eHSP70 between lean and overweight groups.  
 
Methods 
Participants. A total of fourteen males volunteered to participate in the study 
and were split into two groups i) Lean (LEAN, n=7; BMI <25 kg.m-2, body fat <15% 
and fat mass < 12kg) and ii) Overweight (OW, n=7; BMI > 27.0 kg.m-2, body fat 
>20% and fat mass >25kg). Participant characteristics are provided in table 1. All 
participants were healthy, non-smokers with no history of cardiovascular, 
haematological or metabolic disorders and had been weight stable for ≥ 3 months. 
Participants were habitually inactive, performing less than 1.5 hours of structured 
physical activity per week and had avoided any hot weather exposure in the previous 
two months, including frequent sauna or spa use.  
Ethical approval. Full ethical approval was granted by the Loughborough 
University Ethical Advisory Committee.  All procedures conformed to the principles 
defined in the Declaration of Helsinki. Participants were fully informed of the 
experimental protocols and any potential risks were identified before they provided 
their written consent to participate. 
Experimental overview. Participants visited the laboratory on three occasions. 
Visit one consisted of preliminary measures including a blood profile, body 
composition and both submaximal and maximal oxygen uptake tests (Vሶ Oଶ ୫ୟ୶ test). 
Visits two and three comprised the experimental trials which consisted of either 60 
minutes of passive heating via warm water immersion (PH), or 60 minutes of exercise 
at a fixed rate of metabolic heat production (EX) which were completed in a 
counterbalanced order and were matched for ∆Tc. On arrival, participants were asked 
to void their bladder and were weighed in minimal clothing and then fully 
instrumented. Participants then completed either PH or EX as detailed below. On 
completion of each trial a second blood sample and muscle temperature measure were 
obtained, with a final blood sample being taken 2 hours after completion (figure 1). 
Experimental trials were separated by a minimum of 5 days to reduce any acclimation 
effect31 and to minimise any effect of prior exercise or heating upon insulin 
sensitivity.32 All trials were completed at the same time of day to minimise effects of 
circadian variation. 
 Preliminary visit. Participants arrived in a fasted state and a capillary blood 
sample was drawn for assessment of total cholesterol, high density lipoprotein (HDL-
C), low density lipoprotein (LDL-C), glucose and triglycerides (TG) (Cardiochek, 
Polymer Technology Systems, Indianapolis, IN). Participants’ height and weight were 
recorded (Seca 360, Birmingham, UK), and BMI calculated. Body composition was 
determined with skinfold callipers (Harpenden, Warwickshire, UK) using the 7-site 
formula.33 Participants then completed a submaximal exercise test on an electronically 
braked cycle ergometer (Lode Excalibur Sport, Groningen, Netherlands) with an 
online gas analyser (Metamax 3B, Cortex Biophysik GmbH, Germany). The test 
comprised four stages, increasing by 20 W every 4 minutes. Vሶ Oଶ  and Vሶ COଶ were 
determined over a 30 second rolling average from the final minute of the each stage. 
On completion of the submaximal test, participants were given a minimum of a 10-
minute recovery period prior to commencing the Vሶ Oଶ ୫ୟ୶  test. This test used a 
continual ramp protocol at a rate of 20 W.min-1 until the participant reached volitional 
exhaustion. Vሶ Oଶ ୫ୟ୶ was determined over a 30 second rolling average from the final 
minute of the test. 
Experimental trials. Seventy-two hours prior to the start of each experimental 
trail, participants reported to the laboratory where they were fitted with a continuous 
glucose monitor device (CGM; Freestyle Libre, Abbott Laboratories, Berkshire). The 
sensor was inserted on the posterior aspect of the upper limb, with interstitial glucose 
measured every 15 minutes from thereon. CGM data were analysed for 2-h post meal 
glucose area under the curve and peak glucose concentration.34 Participants were 
provided with scales (HoMedics Group Salter, Kent) and detailed instruction on how 
to measure dietary intake in order to accurately complete a 3-day diet diary during the 
first trial, which commenced 24 h before and ended 24 h after completion of trial 1. 
Participants were instructed to consume the first meal after each condition following a 
standardised 3-hour time period. Participants were then required to replicate their 
dietary intake for the second trial.  
Exercise trial. Participants performed 1 hour cycling at a fixed rate of 
metabolic heat production (ܪሶ௣௥௢ௗ) equivalent to 7 W/kg in an environmental chamber 
(25.6 ± 0.7°C; 49.8 ± 3.8% relative humidity, rh). The initial workload was 
determined from the submaximal test and external workload was manipulated 
throughout the 60 minutes in order to maintain ܪሶ௣௥௢ௗ  at 7 W/kg. Participants 
completed the exercise at a self-selected cadence. Vሶ Oଶ and Vሶ COଶ  were recorded 
throughout using an online gas analyser. Airflow was provided by three fans stacked 
vertically, positioned 2.5m in front of the ergometer at an air speed of 1.5 m.s-1.  
Passive heating trial. Participants were seated in a water bath (40.2 ± 0.2 ˚C) 
and immersed up to the waist for 1 hour. Water was circulated throughout to ensure 
maintenance of water temperature. ሶܸ Oଶ and  ሶܸ COଶ  recorded throughout. Ambient 
conditions during the trial were 23.9 ± 0.9 ˚C; 49.9 ± 4.4 % rh.  
Owing to the effect of temperature and duration on HSP72 and IL-6 
expression, we attempted to match the change in core temperature between conditions 
by eliciting a 1˚C increase in core temperature. Furthermore, the duration of both 
exercise and passive heating was matched to limit the effect of intervention exposure 
time on key outcome measures. 
Instrumentation. Core temperature (TC) was measured using a rectal 
thermistor (Grant Instruments Ltd, Cambridge) inserted 10 cm beyond the anal 
sphincter. Wireless skin sensors (iButtons, DS1922, California, USA) were applied 
and secured by Medipore tape (3M, Berkshire, UK). Mean skin temperature ( തܶ௦௞) was 
calculated according to the formula of Ramanathan.35 Participants wore a heart rate 
monitor throughout (RS800, Kempele, Polar, Finland). Estimations of whole body 
sweat loss were made from changes in body mass, which were corrected for fluid 
intake and respiratory fluid loss.  
Muscle temperature. Muscle temperature (Tm) was measured in the right 
vastus lateralis using a solid needle probe (MKA08050A275TS Ellab, Copenhagen, 
Denmark) immediately pre and post-trial. Following standard sterile procedure, the 
needle probe was first inserted to an initial depth of 3 cm beyond the muscle fascia 
where the temperature was allowed to stabilise before the probe was withdrawn to 
2cm and then 1cm depths, with the temperature recorded at each depth.   
Blood sampling. Venous blood samples were collected by venepuncture from 
an antecubital vein in the right arm into a 10 mL Vacutainer that had been pre-cooled 
and pre-treated with K3EDTA (BD Biosciences, San Diego, USA). Samples were 
obtained before and on completion of each heating protocol with a final sample taken 
120 minutes later (figure 1). Samples were stored on ice until they were centrifuged at 
3,500 rpm for 10 min at 4°C and the plasma stored at -80°C until subsequent analysis.  
Enzyme-linked immunosorbent assays. Plasma HSP70 (ENZ-101, AMP’D® hs 
HSP70, Enzo Life Sciences, Exeter, UK) and IL-6 (HS600B, Quantikine® HS IL-6, 
R&D Systems, Abingdon, UK) concentrations were analysed using sandwich 
enzyme-linked immunosorbent assays (ELISAs) according to the manufacturers’ 
instructions. Plasma HSP70 and IL-6 concentrations were determined in relation to a 
four-parameter standard curve (version 6.0 GraphPad Software, La Jolla, CA, USA). 
All samples were analysed in duplicate with a mean intra plate coefficient of variation 
(CV) of 4.5% for HSP70 and 5.8% for IL-6. The inter plate CV was 6.3% for HSP70 
and 6.1% for IL-6.   
Calculations. Energy expenditure during PH and EX was calculated via 
indirect calorimetery. Heat balance parameters were estimated via partitional 
calorimetery and are presented as the mean value for each condition. All parameters 
were calculated in W/m2 but presented as W/kg where appropriate. The rate of 
metabolic energy expenditure was estimated as: 
 
ܯ (ܹ/݉ଶ) =  ሶܸ ܱଶ  ∙
ቂቀܴܧܴ − 0.70.3 ቁ ∙ ݁௖ቃ + ቂቀ
1.0 − ܴܧܴ
0.3 ቁ ∙ ௙݁ቃ
60 ∙ ܤܵܣ ∙ 1000  
(1) 
where RER is the respiratory exchange ratio and ec and ef represent the energy 
equivalent of carbohydrate (21.13 kJ) and fat (19.69 kJ) respectively per litre of O2 
consumed per minute (L.min-1). ܪሶ௣௥௢ௗ was determined as the difference between M 
and the external work rate (W): 
 
ܪሶ௣௥௢ௗ (ܹ/݉ଶ) = M – W    
(2)   
Mean body temperature (∆ തܶ௕) was estimated using the three-compartment model as 
follows: 
 
∆ തܶ௕  = (0.63 ∆ ௖ܶ) + (0.24 ∆ തܶ௦௞) + (0.13 ∆ ௠ܶ)  
(3) 
where ∆Tc represents the change in core temperature, ∆ തܶ௦௞ the change in mean skin 
temperature and ∆Tm the change in muscle temperature at a depth of 3cm.36 Area 
under the curve (AUC) was calculated using the trapezoid method. 
Statistical analysis. The normality and distribution of data was assessed using 
the Shapiro-Wilk normality test. Where data failed to meet the criteria of normal 
distribution the data were log transformed. Mean participant characteristics were 
compared using independent samples t-tests. Tc, തܶ௦௞, Tm, HSP70, IL-6, were analysed 
using repeated measures ANOVA. Where significance was obtained post hoc tests 
were completed using Sidak’s test for multiple comparisons. ܪሶ௣௥௢ௗ, ∆ തܶ௕ and energy 
expenditure were analysed using one-way ANOVA with Sidak’s test for multiple 
comparisons. Correlational analysis was done using Pearson’s correlation coefficient. 
Linear regression was used to analyse the relative contributions of ∆Tc , ∆Tsk, ∆Tm and 
∆ തܶ௕ to ∆HSP70 and ∆IL-6. The R2 value was employed to determine the variance 
explained by each predictor variable. Where reported, the adjusted R2 value is 
provided for multiple linear regression in order to account for the number of predictor 
variables in the model.  All statistical analyses were performed using GraphPad Prism 
(version 6.0 GraphPad Software, La Jolla, CA, USA). All data are presented as mean 
± SD unless otherwise stated. P values ≤ 0.05 were considered statistically significant. 
Effect sizes (ES) corrected for bias using Hedge’s g were calculated as the ratio of the 
mean difference to the pooled standard deviation of the difference, with 95% 
confidence intervals (95% CI) for differences also presented. The magnitude of the 
ES was classed as trivial (<0.2), small (0.2– 0.6), moderate (0.6– 1.2), large (1.2– 2.0) 
and very large (≥ 2.0).37 
 
Results 
 ܪሶ௣௥௢ௗ. There were differences in ܪሶ௣௥௢ௗ between PH (1.9 ± 0.2 W/kg) and EX 
(7.3 ± 0.5 W/kg, P<0.001). ܪሶ௣௥௢ௗ was successfully matched between groups for both 
PH  (LEAN 2.0 ± 0.2 W/kg, OW = 1.8 ± 0.2 W/kg, P=0.433, CI = -0.03 to 0.43, 
ES=0.9) and EX (LEAN 7.3 ± 0.4, OW 7.2 ± 0.5 W/kg; P=0.763, CI = -0.63 to 0.43, 
ES = 0.21). However, when lean body mass is accounted for, differences in ܪሶ௣௥௢ௗ 
were evident (LEAN 8.4 ± 0.4 W/kg/LBM-1; OW 9.8 ± 1.6 W/kg/LBM-1, P<0.05, CI 
= 0.04 to 2.76, ES=1.1). 
eHSP70. There was a main effect of time (P<0.005) but not condition (P = 
0.887) on the eHSP70 response (figure 2A). The increase in eHSP70 following PH 
and EX was 23% and 24% respectively (figure 2B). There was a large effect of group 
on the change in eHSP70 following PH (40.2% vs. 13.2%, P = 0.273, CI = 2.9 to 
51.1, ES = 1.4) and a small effect following EX (37% vs. 14%, P = 0.340, CI = -48.1 
to 94.9, ES = 0.4), although this did not reach statistical significance.. Across 
conditions ∆eHSP70 correlated with mean Tm (r=0.485, P<0.05). ∆eHSP70 was 
negatively correlated to body mass (r = -0.400, P<0.05). Of the thermal variables, ∆Tm 
provided the best predictor of ∆HSP70, with the ∆Tm explaining 24.7% of the total 
variance in ∆HSP70 (r=0.498, P<0.01). Body mass also predicted ∆HSP70, 
explaining 16.4% of the total variance (r = -0.405, P<0.05). When combined, ∆Tm and 
body mass provided the strongest predictor, accounting for 28% of the variance in 
∆HSP70 (Adjusted R2 = 0.280, r = 0.585, P<0.01). 
 IL-6. There was a main effect of time (P<0.001), condition (P<0.05) and an 
interaction effect (P<0.01, figure 2C) on IL-6 concentration. IL-6 was higher 
immediately following EX (1.74 ± 1.79 pg.mL-1) compared to PH (0.97 ± 0.86 pg.mL-
1, P<0.0001, ES=0.5) and equated to an increase of 346% after EX and 118% 
following PH (figure 2D) from baseline values. IL-6 had returned to baseline at 2h 
post for PH (0.58 ± 0.47 pg.mL-1) and EX (0.73 ± 0.79 pg.mL-1). When considering 
differences between LEAN and OW, there was a main effect of time (P<0.05) but not 
group (P = 0.533) on the IL-6 response. None of the thermal variables, nor body 
mass, provided an effective model for predicting the change in IL-6. 
Energy expenditure. There were no differences in resting metabolic rate 
between LEAN (1811.2 ± 82.3 kcal.day-1) and OW (1873.9 ± 140.7 kcal.day-1; P = 
0.330, ES = 0.5).  There was an overall effect of condition on energy expenditure 
during heating (P<0.0001) and an interaction effect (P<0.05). PH increased energy 
expenditure by 61.0 ± 14.4 kcal compared to rest (P<0.0001, ES = 4.8), which equates 
to a 79.5% increase. EX resulted in an additional energy expenditure of 556.3 ± 92.0 
kcal compared to rest (P<0.0001, ES = 7.1), equating to a 721% increase. EX energy 
expenditure was greater for OW compared to LEAN (11.3 ± 1.9 kcal.min-1 vs. 9.8 ± 
0.9 kcal.min-1 respectively, P<0.05, ES = 1.0), resulting in an additional caloric 
expenditure from rest of 597.7 ± 107.9 kcal for OW (748%), and 515 ± 52.1 kcal for 
LEAN (681%). During PH, there was no difference in the increase in energy 
expenditure between LEAN and OW (2.3 ± 0.3 kcal.min-1 vs. 2.3 ± 0.3 kcal.min-1   
respectively, P = 0.997, ES = 0.0). Caloric expenditure increased from rest by 63.4 ± 
16.6 kcal (84%) and 58.5 ± 12.7 kcal (74%) kcal for LEAN and OW respectively 
although there was no difference between groups (P=0.623, ES = 0.3). 
Substrate oxidation. Total EX carbohydrate oxidation was higher for OW 
(125.3 ± 20.8 g) compared to LEAN (92.5 ± 28.2 g; P<0.05, ES=1.3). There was a 
moderate effect of body mass on total carbohydrate oxidation in PH between OW (7.5 
± 4.2 g) and LEAN (13.2 ± 8.3 g, ES=0.83) although this did not reach significance 
(P=0.13). There was no difference between OW and LEAN in total fat oxidation 
during EX (P=0.46). There was a tendency for OW to display a greater total fat 
oxidation than LEAN in PH, although this did not reach statistical significance 
(10.6±1.54g vs. 9.0±3.1g; ES 0.7; P=0.13).   
 Continuous glucose monitoring. Owing to instances of poor compliance to diet 
replication and sensor malfunction and drop out, CGM analysis was only completed 
on 8 participants, with an unequal split between LEAN and OW. Therefore, it was 
only possible to conduct analysis on PH compared to EX. Peak glucose concentration 
in response to the meal following PH (6.3 ± 1.4 mmol.L-1) was lower compared to the 
same meal after EX (6.8 ± 1.2 mmol.L-1; P<0.05, CI = -0.9 to 1.9, ES = 0.4, figure 
4a). There was no difference in glucose AUC for PH compared to EX following this 
meal (P=0.875, CI = -11.2 to 12.4, ES = 0.1 figure 4b). There was no difference in 
24h AUC between PH and EX. 
Core temperature. There was a main effect of time (P<0.0001) and an 
interaction effect (P<0.0001), but no main effect of condition on ∆Tc (P = 0.112, 
figure 4a). PH ∆Tc was lower in OW compared to LEAN from 35 minutes (P<0.05), 
although by 60 minutes there was no difference in ∆Tc  (1.0 ± 0.2˚C vs. 0.9 ± 0.2˚C, 
LEAN vs. OW respectively P = 0.089, CI = -0.13 to 0.33, ES = 0.5). There were no 
differences in ∆Tc between OW and LEAN during EX at any time point, with ∆Tc at 
60 minutes being 0.8 ± 0.1˚C vs. 0.8 ± 0.2˚C for LEAN and OW respectively 
(P=0.999). 
 Skin temperature. There were main effects of time (P<0.0001), condition 
(P<0.0001) and an interaction effect (P<0.0001) on ∆ തܶ௦௞ (figure 4B). There were no 
differences in ∆ തܶ௦௞ between OW and LEAN following EX (LEAN 1.7 ± 0.7˚C vs OW 
1.7 ± 1.6˚C, P=0.999, ES=0.0) or PH (LEAN 4.2 ± 0.4˚C vs OW 4.7 ± 0.6˚C, 
P=0.095, ES=0.9). 
 Muscle temperature. There was an effect of depth on ∆Tm  (P<0.001), but no 
effect of condition (P=0.285) or interaction (P=0.111, figure 4C). Following PH, the 
∆Tm was greater for LEAN compared to OW at a depth of 1cm (LEAN, 2.5 ± 0.8˚C; 
OW 1.9 ± 0.6˚C, P<0.0005, CI = -0.2 to 1.4, ES=0.8) and 3cm (LEAN, 2.3±0.6˚C; 
OW 1.9± 0.7, P<0.005, CI = -0.4 to 1.2, ES=0.6). After EX, ∆Tm was only different at 
1cm (LEAN, 2.3±0.6˚C; OW 2.0 ± 0.7, P<0.005, CI = -0.5 to 1.1, ES = 0.4). 
 Mean body temperature. There was a difference in ∆ തܶ௕  between conditions 
(P<0.0001, figure 4D). There were differences between LEAN PH and LEAN EX 
(1.7 ± 0.3˚C vs. 1.1 ± 0.3 ˚C, P<0.005, CI = 0.3 to 1.0, ES = 1.9); OW PH and OW 
EX (1.8 ± 0.2˚C vs. 1.0 ± 0.4˚C; P<0.001, CI = 0.4 to 1.2, ES = 2.4). There were no 
differences between LEAN and OW within the same condition (both P>0.9). 
 Heart rate. There were significant effects of time, condition and interaction 
effect of heart rate (all P<0.0001). Mean percentage HRmax EX was 78±8% compared 
to 54±7% in PH (P<0.0001). There were no differences in the mean percentage of 
HRmax between groups for either PH (LEAN = 54.0 ± 6.0% vs. OW = 55.2 ± 6.2%, 
P=0.719) or EX (LEAN = 78.5 ± 7.3%; OW = 81.7 ± 7.4%, P=0.428).  
 
Discussion 
 The primary outcome of the present study was that the concentration of 
eHSP70 in the plasma was similar between EX and PH when both conditions were 
matched for ∆Tc, with ∆Tm being the best individual predictor of ∆eHSP70, 
explaining ~25% of the total variance. This suggests that changes to Tm are an 
important determinant of eHSP70 appearance and that the HSP70 response may be 
hindered by excess body mass. An important secondary outcome is the increase in 
energy expenditure evident as a consequence of PH. This has important implications 
for the use of PH as an intervention that may help to reduce body fat, particularly for 
individuals unable or unwilling to complete regular physical activity. Finally, the 
reduction in peak glucose in the meal following PH compared to EX suggests that PH 
may have a beneficial effect on glycaemic regulation and provide an alternative or 
augmentative intervention by which individuals with metabolic diseases may be able 
to improve their glycemic control. However, additional research needs to be 
conducted to confirm these data in larger cohorts over a prolonged period of time. 
A greater degree of variability in the eHSP70 response to heating in the OW 
group was evident. Regression analysis demonstrated a link between body mass and 
the ∆eHSP70. A greater body mass was associated with an impaired eHSP70 response 
to heating, via either EX or PH, explaining 16% of the total variance. Such variation 
may be indicative of an impaired HSP response in overweight individuals in the face 
of physiological stress and would likely be compounded by low aerobic capacity.38 
The implications for such a deficiency are wide ranging and may increase 
susceptibility to metabolic disease38,39 and impaired vascular function.40 
Chronic exercise training causes diminishing elevations in eHSP70 with each 
bout of subsequent exercise, whilst iHSP70 concentration increases. Such changes in 
the compartmentalised concentration of HSP70 will lead to a shift in the ratio of 
iHSP70 to eHSP70. This ratio is postulated to be important in determining the 
systemic inflammatory profile and associated insulin resistance,9 with a shift in favour 
of iHSP70 lowering inflammation and improving insulin sensitivity. However, given 
the variability in the HSP70 response in OW, any such changes to iHSP70:eHSP70 
will likely require long term PH in order to achieve a positive balance in favour of 
iHSP70. Given the suggested mechanism through which HSP70 may influence insulin 
signalling,41 the increase in iHSP70 represents a critical adaptation through which 
passive heating may elicit positive metabolic effects. 
An increase in iHSP70 has been reported previously following 12 weeks of 
heat therapy and was associated with reductions in HbA1c, fasting glucose and 
insulin.42 The beneficial effects of iHSP70 relating to insulin resistance and 
metabolism are suggested to occur by increasing mitochondrial number and oxidative 
capacity.18,43 Given the link between reduced HSP70 and T2DM18 it appears that an 
intervention capable of inducing HSP70 in humans would be effective at alleviating 
some of the symptoms of metabolic diseases.25 The present data demonstrates 
comparable increases in eHSP70 following either PH or EX, therefore it is possible 
that PH may offer a mechanism by which individuals who are unwilling or unable to 
exercise regularly, could augment similar beneficial effects by incorporating passive 
heating into their daily routine. 
 Whilst there were no clear differences in the HSP70 response between either 
PH or EX, there were clear differences in the IL-6 response. Previous work has shown 
that temperature increases independently elevate IL-6.44 However, the present data 
does not support the view that skeletal muscle may act as a “heat stress sensor” 
triggering a subsequent cytokine response, as none of the thermal measures taken 
during the trials were effective predictors of ∆IL-6 and could not account for a 
significant proportion of the variation in IL-6 following heating. Our data also 
indicate that the difference in IL-6 between PH and EX is not due to HSP70 induction 
of IL-645,46 as ∆HSP70 was similar following PH and EX. This suggests the IL-6 
response to exercise occurs independently of HSP70 expression and is more 
dependent on intensity and duration of exercise,47 or exposure to heat stress. IL-6 
combined with its receptor (IL-6R), may also be a pathway by which insulin 
independent glucose uptake occurs at rest.48 Should chronic PH enhance IL-6R 
expression as is evident following exercise training,49 interventions capable of 
increasing both IL-6 and IL-6R, may provide a therapeutic basis for improving 
glycemic control. Moreover, it has recently been shown that acute passive heating 
elevates the anti-inflammatory cytokines IL-1ra and IL-10,50 suggesting that chronic 
passive heating may benefit the inflammatory profile in a similar way to exercise, 
albeit to a lesser extent, although long term investigation of PH is required to 
corroborate this hypothesis.  
IL-6 appears to play a central role in the metabolic activity of brown adipose 
tissue (BAT). In a rodent model, BAT transplanted from IL-6 knockout mice did not 
display its characteristically profound metabolic effect on glucose homoeostasis and 
insulin sensitivity.51 Coupled with the present data, this suggests that PH induced 
elevations in energy expenditure may occur as a consequence of IL-6 derived 
elevation in BAT activity. Although this was not determined in the present study, it 
presents an intriguing line for future research. 
 In addition to benefits to metabolic regulation, PH has been shown to benefit 
cardiovascular health. In a recent meta-analysis Laukkanen et al., report that lifelong 
sauna use reduced cardiovascular and all cause mortality, with the largest benefits 
associated with more frequent sauna use.52 Although this relationship does not 
establish causality 28,53 it is nonetheless and interesting link that is supported by recent 
investigations.54,55 PH appears to improve vascular function, with improvements to 
flow-mediated dilatation, arterial stiffness and blood pressure reported after 8 weeks 
of PH.54 Moreover, Thomas et al., have shown that 30 minutes of PH can induce a 
greater shear stress response and reduction in mean arterial pressure compared to 
matched duration exercise, in patients with peripheral arterial disease.55 Based on 
heart rate responses, the cardiovascular strain in the present study was comparable to 
that of Thomas et al., which elicited ~50% HRmax during their immersion protocol. 
These recent findings indicate that PH has the potential to induce significant systemic 
benefits, which in some instances may be comparable to or even greater than the 
effects evident following exercise. 
 In summary, the data presented here demonstrate that both acute PH and EX 
result in comparable increases in HSP70. It is suggested that ∆HSP70 is sensitive to 
the ∆Tm. The elevations in both HSP70 and IL-6 may promote an anti-inflammatory 
milieu and help combat the chronic inflammation associated with many disease states. 
The increase in energy expenditure following PH demonstrates a systemic effect of 
PH, which has the ability to reduce adipose tissue and further contribute to reducing 
inflammation. Finally, the present data, in agreement with that of other authors, 
indicates that PH might provide an alternative to exercise in some individuals who are 
too physically impaired to undertake prolonged aerobic activity to improve their 
cardio-metabolic health. 
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Table 1. Participant characteristics.  
Lean Overweight 
Age (years) 23.9 ± 3.5 30.7 ± 12.0 
Height (m) 1.83 ± 0.05 1.78 ± 0.05* 
Weight (kg) 78.9 ± 7.01 92.3 ± 12.3* 
BMI (kg.m2) 23.5 ± 2.2 29.2 ± 2.7** 
Waist (cm) 79.6 ± 4.8 92.9 ± 8.2** 
Hip (cm) 99.6 ± 4.4 105.1 ± 6.8 
Waist:Hip 0.80 ± 0.03 0.88 ± 0.04** 
BP Systolic 130 ± 14 137 ± 10 
BP Diastolic 77 ± 12 87 ± 0 
Cholesterol (mmol.L-1) 3.27 ± 0.54 3.71 ± 1.04 
LDL-C (mmol.L-1) 1.5 ± 0.5 1.8 ± 0.6 
HDL-C (mmol.L-1) 1.3 ± 0.3 1.2 ± 0.2 
Glucose (mmol.L-1) 4.6 ± 0.6 4.1 ± 0.8 
Triglyceride (mmol.L-1) 1.1 ± 0.2 1.6 ± 0.8 
Body fat (%) 12.5 ± 5.5 20.3 ± 1.6*** 
Fat Mass (kg) 10.1 ± 5.1 28.1 ± 9.9** 
Lean mass (kg) 68.8 ± 4.2 64.2 ± 6.9 
Vሶ Oଶ ୫ୟ୶ (L.min-1) 3.86 ± 0.35 3.35 ± 0.81 
Vሶ Oଶ ୫ୟ୶ (mL.kg.min-1) 49.03 ± 5.74 36.60 ± 9.66* 
Percent Vሶ Oଶ ୫ୟ୶  – EX (%) 53.9 ± 7.5 69.2 ± 10.2** 
Percent Vሶ Oଶ ୫ୟ୶  – PH (%) 18.3 ± 6.7 25.5 ± 6.7 
Basal Metabolic Rate (kcal.day-1) 1811.2 ± 82.3 1873.9 ± 140.7 
Data presented as mean ± SD. Asterix denotes * (P<0.05); ** (P < 0.01); *** (P<0.005). Abbreviations: BMI – Body mass 
index, BP – blood pressure, EX – Exercise trial, HDL – High density lipoprotein, LDL – Low density lipoprotein, PH – Passive 
heating trial, TG – Triglyceride 
 
 
 
 
 
 
 
 
 
Figure 1: Schematic representation of the experimental trials. PH, passive heating; 
EX, exercise; CGM, continuous glucose monitoring. 
 
Figure 2: The effect of 60 minutes passive heating at 40˚C, exercise at 7 W/kg and 
body composition on IL-6 and HSP70. A) the effect of passive heat and exercise on 
HSP70; B) the change in IL-6 in response to heating.  C) The effect of passive heat 
and exercise on IL-6; D) the change in IL-6 in response to heating. *above the line 
denotes main effect of time. †denotes difference between passive heating and 
exercise. Data presented as mean ± SEM 
 
 
Figure 3: Passive heating resulted in a reduction in peak interstitial glucose 
concentration compared to exercise in the meal immediately following the 
intervention. *denotes passive different to exercise (P<0.05). Data presented as mean 
± SEM. n=8 
   
Figure 4: The effect of 60 minutes passive heating at 40˚C, exercise at 7 W/kg and 
body composition on determinants of mean body temperature. A) the change in core 
temperature, B) change in mean skin temperature, C) muscle temperature at depths of 
1cm, 2cm and 3cm, D) change in mean body temperature. # above line denotes main 
effect of time,  * denotes difference between LEAN and OW in passive heating 
condition (P<0.05). †denotes difference between LEAN and OW in exercise 
condition (P<0.05) **denotes difference between PH and EX within each condition 
Data presented as mean ± SEM 
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